Cargando…

The Impact of Treatment with Beta-Blockers upon Mortality in Chronic Heart Failure Patients

BACKGROUND: Besides the conventional therapy for heart failure, the diuretics, cardiac glycosides and ACE-inhibitors, current pharmacotherapy includes beta-blockers, mainly because of their pathophysiological mechanisms upon heart remodeling. AIM: The study objective was to assess the cardiovascular...

Descripción completa

Detalles Bibliográficos
Autores principales:	Taneva, Borjanka, Caparoska, Daniela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Institute of Immunobiology and Human Genetics 2016
Materias:	Clinical Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4884262/ https://www.ncbi.nlm.nih.gov/pubmed/27275338 http://dx.doi.org/10.3889/oamjms.2016.022

Ejemplares similares

Prevalence of Diabetes Mellitus in Patients with Chronic Kidney Disease
por: Stojceva-Taneva, Olivera, et al.
Publicado: (2016)

Hypercalcemia as a Cause of Kidney Failure: Case Report
por: Stojceva-Taneva, Olivera, et al.
Publicado: (2016)

Treatment optimization of beta-blockers in chronic heart failure therapy
por: Niriayo, Yirga Legesse, et al.
Publicado: (2020)

Mortality reduction with use of oral beta-blockers in patients with acute coronary syndrome
por: de Matos Soeiro, Alexandre, et al.
Publicado: (2016)

Different Impact of Beta-Blockers on Long-Term Mortality in Heart Failure Patients with and without Chronic Obstructive Pulmonary Disease
por: Higuchi, Satoshi, et al.
Publicado: (2021)

Intravenous levosimendan vs. dobutamine in acute decompensated heart failure patients on beta-blockers
por: Bergh, Claes-Håkan, et al.
Publicado: (2010)

Leukocyte Redistribution: Effects of Beta Blockers in Patients with Chronic Heart Failure
por: von Haehling, Stephan, et al.
Publicado: (2009)

The effect of beta-blockers on mortality in patients with heart failure and atrial fibrillation: A meta-analysis of observational cohort and randomized controlled studies
por: Ma, Gai-gai, et al.
Publicado: (2020)

Refractory Epilepsy-MRI, EEG and CT scan, a Correlative Clinical Study
por: Nikodijevic, Dijana, et al.
Publicado: (2016)

Effectiveness and safety of four different beta‐blockers in patients with chronic heart failure
por: Liu, Baoshan, et al.
Publicado: (2023)

Beta‐blocker use and mortality among patients with systolic heart failure and pacemaker rhythm
por: Perry, Andrew S., et al.
Publicado: (2023)

Beta-Blockers and Oxidative Stress in Patients with Heart Failure
por: Nakamura, Kazufumi, et al.
Publicado: (2011)

New advances in beta-blocker therapy in heart failure
por: Barrese, Vincenzo, et al.
Publicado: (2013)

The effect of beta-blockers in acute heart failure according to heart rate
por: Kim, Hyun-Jin, et al.
Publicado: (2021)

Lower In‐Hospital Mortality With Beta‐Blocker Use at Admission in Patients With Acute Decompensated Heart Failure
por: Tamaki, Yodo, et al.
Publicado: (2021)

Beta-blocker treatment in heart failure patients with atrial fibrillation: challenges and perspectives
por: Chourdakis, Emmanouil, et al.
Publicado: (2021)

Impact of beta‐blocker use on the long‐term outcomes of heart failure patients with chronic obstructive pulmonary disease
por: Kubota, Yoshiaki, et al.
Publicado: (2021)

Poor tolerance of beta-blockers by elderly patients with heart failure
por: Yanagisawa, Satoshi, et al.
Publicado: (2010)

Beta Blockers in Heart Failure: More Evidence for an Old Friend
por: Baek, Sang Hong
Publicado: (2018)

Association of digoxin with mortality and rehospitalization in heart failure patients treated with beta-blockers: Results from the Persian Heart Failure Patient Registry
por: Yazdi, Maryam, et al.
Publicado: (2022)

Adherence to beta‐blockers and long‐term risk of heart failure and mortality after a myocardial infarction
por: Desta, Liyew, et al.
Publicado: (2020)

Beta-blocker therapy in elderly patients with renal dysfunction and heart failure
por: Martínez-Milla, Juan, et al.
Publicado: (2021)

Effects of Holding Beta-Blockers on the Vital Signs of Heart Failure Patients
por: Erickson, Marc, et al.
Publicado: (2021)

Beta-blockers and mechanical dyssynchrony in heart failure assessed by radionuclide ventriculography
por: Jones, K. A., et al.
Publicado: (2022)

Is heart rate reduction more important than target dose in chronic heart failure therapy with a beta-blocker?
por: Guo, Yong-Fang, et al.
Publicado: (2011)

Adding ivabradine to beta-blockers in chronic heart failure: Do not rest without lowering the resting heart rate sufficiently
por: Oomman, Abraham, et al.
Publicado: (2018)

Treatment of heart failure with ACE inhibitors and beta-blockers: What is next? Aldosterone receptor antagonists?
por: van der Horst, Iwan C. C., et al.
Publicado: (2007)

Clinical impacts of additive use of olmesartan in hypertensive patients with chronic heart failure: the supplemental benefit of an angiotensin receptor blocker in hypertensive patients with stable heart failure using olmesartan (SUPPORT) trial
por: Sakata, Yasuhiko, et al.
Publicado: (2015)

A Review of the External Validity of Clinical Trials with Beta-Blockers in Heart Failure
por: Iyngkaran, Pupalan, et al.
Publicado: (2016)

Beta-blocker Therapy at Discharge in Patients with Acute Heart Failure and Atrial Fibrillation
por: Ahn, Min-Soo, et al.
Publicado: (2020)

Using machine learning to uncover heterogeneity of beta blocker response in heart failure
por: Tison, Geoffrey H.
Publicado: (2022)

Adherence and optimization of angiotensin converting enzyme inhibitor/angiotensin II receptors blockers and beta‐blockers in patients hospitalized for acute heart failure
por: Carubelli, Valentina, et al.
Publicado: (2021)

Neutrophil-to-lymphocyte ratio and in-hospital mortality in patients with acute heart failure
por: Turfan, Murat, et al.
Publicado: (2014)

Resting heart rate in ambulatory heart failure with reduced ejection fraction treated with beta‐blockers
por: Varian, Kenneth D., et al.
Publicado: (2020)

β blockers for heart failure
por: Hoes, Arno W
Publicado: (2016)

Disease-modifying medications in heart failure: more than ACE inhibitors and beta blockers
por: Chao, Chia-Ter
Publicado: (2011)

Self-Reported and Actual Beta-Blocker Prescribing for Heart Failure Patients: Physician Predictors
por: Sinha, Sanjai, et al.
Publicado: (2009)

Individual patient data meta-analysis of beta-blockers in heart failure: rationale and design
por: Kotecha, Dipak, et al.
Publicado: (2013)

Effects of Beta-Blockers on Heart Failure with Preserved Ejection Fraction: A Meta-Analysis
por: Liu, Feng, et al.
Publicado: (2014)

Beta-blockers in heart failure prognosis: Lessons learned by MECKI Score Group papers
por: Cattadori, Gaia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_m0nejs914if7gnlpaut9ro8c87